Sekar Kathiresan

Last updated

Sekar Kathiresan is chief executive officer and co-founder of Verve Therapeutics. Verve is pioneering a new approach to the care of cardiovascular disease by developing single-course gene-editing therapies that safely and durably lower plasma LDL cholesterol in order to treat atherosclerotic cardiovascular disease.

Contents

Kathiresan is a cardiologist and a geneticist who has helped define the inherited basis for heart attack risk and made groundbreaking discoveries of genetic mutations which confer resistance to cardiovascular disease. [1] Prior to joining Verve in July 2019, he served as director of the Massachusetts General Hospital Center for Genomic Medicine and was the Ofer and Shelly Nemirovsky MGH Research Scholar. He also served as director of the Cardiovascular Disease Initiative at the Broad Institute and was a Professor of Medicine at Harvard Medical School.

Kathiresan’s research laboratory focused on understanding the inherited basis for blood lipids and myocardial infarction and using these insights to improve preventive cardiac care. Among his scientific contributions, Kathiresan has helped highlight new biological mechanisms underlying heart attack, discovered mutations that protect against heart attack risk, highlighted triglyceride-rich lipoproteins as a therapeutic target, and developed a framework to interpret the genome for heart attack risk which includes monogenic, somatic, and polygenic drivers of disease risk. He has over 152,000 citations and a h-index of 138 according to Google Scholar. [2]

For his research contributions, he has been honored with a Distinguished Scientist Award from the American Heart Association and the 2018 Curt Stern Award from the American Society of Human Genetics. His clinical focus is the prevention of myocardial infarction in individuals with a family history of heart attack.

Education

He received his M.D. from Harvard Medical School in 1997. He then completed his clinical training in internal medicine and cardiology at Massachusetts General Hospital, where he served as chief resident in Internal Medicine from 2002 to 2003. Kathiresan pursued postdoctoral research training from 2003 to 2008 in cardiovascular genetics through a combined experience at the Broad Institute and the Framingham Heart Study, jointly mentored by Drs. David Altshuler, Joel Hirschhorn, and Christopher J. O'Donnell. In 2008, he joined the faculty of the Massachusetts General Hospital Cardiology Division, Cardiovascular Research Center, and Center for Genomic Medicine. Prior to medical school, he received his B.A. in history with Honors and graduated summa cum laude from the University of Pennsylvania in 1992 and earlier, Kathiresan attended North Allegheny public schools in Pittsburgh and graduated valedictorian of North Allegheny Senior High School in 1988.

Awards

Related Research Articles

<span class="mw-page-title-main">Coronary thrombosis</span> Medical condition

Coronary thrombosis is defined as the formation of a blood clot inside a blood vessel of the heart. This blood clot may then restrict blood flow within the heart, leading to heart tissue damage, or a myocardial infarction, also known as a heart attack.

<span class="mw-page-title-main">University of Ottawa Heart Institute</span> Hospital in Ottawa, Ontario

The University of Ottawa Heart Institute (UOHI) (French: Institut de cardiologie de l'Université d'Ottawa ) is Canada's largest cardiovascular health centre. It is located in Ottawa, Ontario, Canada. It began as a department in The Ottawa Hospital, and since has evolved into Canada's only complete cardiac centre, encompassing prevention, diagnosis, treatment, rehabilitation, research, and education.

<span class="mw-page-title-main">Brigham and Women's Hospital</span> Hospital in Massachusetts, United States

Brigham and Women's Hospital (BWH) is the second largest teaching hospital of Harvard Medical School and the largest hospital in the Longwood Medical Area in Boston, Massachusetts. Along with Massachusetts General Hospital, it is one of the two founding members of Mass General Brigham, the largest healthcare provider in Massachusetts. Robert Higgins, MD, MSHA serves as the hospital's current president.

Stephen E. Epstein is the Head of Translational and Vascular Biology Research at the MedStar Heart and Vascular Institute, MedStar Washington Hospital Center and Clinical Professor of Medicine at the Georgetown University School of Medicine.

<span class="mw-page-title-main">Paul Ridker</span> American epidemiologist and academic

Paul M. Ridker is a cardiovascular epidemiologist and biomedical researcher. He is currently the Eugene Braunwald Professor of Medicine at Harvard University and Brigham and Women's Hospital, where he directs the Center for Cardiovascular Disease Prevention. Ridker also holds an appointment as Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.

Eugene Braunwald is an Austrian-born American cardiologist.

<span class="mw-page-title-main">Troponin I</span> Muscle protein

Troponin I is a cardiac and skeletal muscle protein family. It is a part of the troponin protein complex, where it binds to actin in thin myofilaments to hold the actin-tropomyosin complex in place. Troponin I prevents myosin from binding to actin in relaxed muscle. When calcium binds to the troponin C, it causes conformational changes which lead to dislocation of troponin I. Afterwards, tropomyosin leaves the binding site for myosin on actin leading to contraction of muscle. The letter I is given due to its inhibitory character. It is a useful marker in the laboratory diagnosis of heart attack. It occurs in different plasma concentration but the same circumstances as troponin T - either test can be performed for confirmation of cardiac muscle damage and laboratories usually offer one test or the other.

Avijit Lahiri is a researcher in cardiology in the UK.

<span class="mw-page-title-main">Eric Topol</span> American cardiologist, scientist, and author

Eric Jeffrey Topol is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California. He has published three bestseller books on the future of medicine: The Creative Destruction of Medicine (2010), The Patient Will See You Now (2015), and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (2019). He was commissioned by the UK from 2018–2019 to lead planning for the National Health Service's future workforce, integrating genomics, digital medicine, and artificial intelligence.

<span class="mw-page-title-main">Valentín Fuster</span> Spanish cardiologist

Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat.

<span class="mw-page-title-main">Myocardial infarction</span> Interruption of blood supply to a part of the heart

A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing infarction to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck or jaw. Often such pain occurs in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like heartburn. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, feeling tired, and decreased level of consciousness. About 30% of people have atypical symptoms. Women more often present without chest pain and instead have neck pain, arm pain or feel tired. Among those over 75 years old, about 5% have had an MI with little or no history of symptoms. An MI may cause heart failure, an irregular heartbeat, cardiogenic shock or cardiac arrest.

Kåre Ingmar Berg, MD was a Norwegian professor in medical genetics, physician-in-chief and well-cited researcher.

<span class="mw-page-title-main">JoAnn E. Manson</span> American physician

JoAnn Elisabeth Manson is an American physician and professor known for her pioneering research, public leadership, and advocacy in the fields of epidemiology and women's health.

Jean-Claude Tardif is the Director of the Research Center at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. He received his medical degree (MD) in 1987 from the University of Montreal and specialized in cardiology and research in Montreal and Boston until 1994. Dr. Tardif holds the Canada Research Chair in personalized medicine and the University of Montreal endowed research chair in atherosclerosis. He is also the Scientific Director of the Montreal Health Innovations Coordinating Center (MHICC).

Salim Yusuf is an Indian-born Canadian physician, the Marion W. Burke Chair in Cardiovascular Disease at McMaster University Medical School. He is a cardiologist and epidemiologist. Yusuf has criticized the Dietary Guidelines for Americans and disputes the scientific consensus on dietary sodium and saturated fat intake.

<span class="mw-page-title-main">Rahul Potluri</span>

Rahul Potluri is a British physician, researcher and founder of ACALM Study Unit, United Kingdom (UK). His clinical epidemiology research unit is one of the first to use big data in healthcare and medical research. His work has shown for the first time a link between high cholesterol and breast cancer. Further research has suggested the role of cholesterol and possibly statins improving the mortality in patients with breast cancer, lung cancer, prostate cancer and bowel cancer. Other prominent studies include health services research evaluating differences in death rates from weekend admission and discharge from UK hospitals, ethnic variations and the interplay between cardiovascular disease and mental health.

Attilio Maseri OMRI KSG was an Italian academic and physician specialized in cardiology, considered a leading researcher in the field of ischemic heart disease. His patients included Queen Elizabeth II and Pope John Paul II.

<span class="mw-page-title-main">Shelby Kutty</span> Indian-born American cardiologist and professor

Shelby Kutty is an Indian-born American cardiologist, a professor of pediatrics and internal medicine at the Johns Hopkins University School of Medicine. He holds the Helen B. Taussig endowed professorship at Johns Hopkins and is Director of the Helen B. Taussig Heart Center at the Johns Hopkins Hospital. Prior to this, he held the title of assistant dean for research and development and vice chair of pediatrics at the University of Nebraska Medical Center College of Medicine.

Harlan M. Krumholz, MD, SM is an American cardiologist, leading research scientist, and the Harold H. Hines, Jr. Professor of Medicine at Yale School of Medicine, where he has been on faculty since 1992. A pioneer in the development of the field of outcomes research, his groundbreaking contributions to science have directly led to improvements in healthcare outcomes for patients and populations. He is an international expert in the science to evaluate and improve the quality and efficiency of care, reduce disparities, improve integrity in medical research, promote better health policies and regulations, and promote patient-centeredness in research and clinical care. He is the founder and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation.

Kiran Musunuru is an American cardiologist who is a Professor of Medicine at the University of Pennsylvania Perelman School of Medicine. He researches the genetics and genomics of cardiovascular and metabolic diseases. Musunuru is a leading expert in the field of gene-editing.

References

  1. "About Sekar - Kathiresan Lab". Kathiresan Lab. Retrieved 2018-05-17.
  2. "Sekar Kathiresan - Google Scholar Citations". scholar.google.com. Retrieved 29 June 2021.
  3. "Harvard scientist gets American Heart Association award for findings of inherited basis for cardiovascular disorders".
  4. "ASHG". 11 July 2018.
  5. "2017 Distinguished Scientist - Sekar Kathiresan, MD, FAHA". professional.heart.org. Retrieved 2018-05-17.
  6. "2013 MGH Research Scholars - Massachusetts General Hospital, Boston, MA". www.massgeneral.org. Retrieved 2018-05-17.
  7. "USNews - Doctors".
  8. "Sekar Kathiresan receives prestigious award to pursue genetic causes of heart disease". Broad Institute. 2006-01-03. Retrieved 2018-05-17.